Clinical trial
Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II
NCT02185768 is registered in ClinicalTrials.gov with Federation Francophone de Cancerologie Digestive as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II
- Lead sponsor
- Federation Francophone de Cancerologie Digestive
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- October 31, 2017
- Enrollment
- 46 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
liver cancer